145 related articles for article (PubMed ID: 36238410)
1. Mediastinal Lymph Node Metastasis from Head and Neck Cancer: Predictive Factors and Imaging Features.
Ko IK; Yoon DY; Baek S; Hong JH; Yun EJ; Lee IJ
Taehan Yongsang Uihakhoe Chi; 2021 Sep; 82(5):1246-1257. PubMed ID: 36238410
[TBL] [Abstract][Full Text] [Related]
2. Intra-parotid lymph node metastasis in patients with non-cutaneous head and neck cancers: clinical and imaging features for differentiation from simultaneous parotid primary tumor.
Kim HJ; Yoon DY; Hong JH; Yun EJ; Baek S; Kim ES; Park MW; Kwon KH
Acta Radiol; 2020 Dec; 61(12):1628-1635. PubMed ID: 32138522
[TBL] [Abstract][Full Text] [Related]
3. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
[TBL] [Abstract][Full Text] [Related]
4. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer.
Lin WY; Hsu WH; Lin KH; Wang SJ
J Chin Med Assoc; 2012 May; 75(5):203-8. PubMed ID: 22632985
[TBL] [Abstract][Full Text] [Related]
5. Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers.
Zhu Y; Cai Q; Wang Y; You N; Yip R; Lee DS; Taioli E; Flores R; Henschke CI; Yankelevitz DF
Lung Cancer; 2021 Nov; 161():189-196. PubMed ID: 34624614
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
[TBL] [Abstract][Full Text] [Related]
7. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Onal C; Oymak E; Findikcioglu A; Reyhan M
Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
9. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
12. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography - Computed tomography for staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
Prisadov G; Blume-Vulin A; Scharpenberg M; Welcker K; Kesieme EB; Linder A
Ann Afr Med; 2023; 22(1):101-106. PubMed ID: 36695230
[TBL] [Abstract][Full Text] [Related]
14. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
[TBL] [Abstract][Full Text] [Related]
15. Impact of EBUS-TBNA in addition to [
Guberina M; Darwiche K; Hautzel H; Ploenes T; Pöttgen C; Guberina N; Herrmann K; Umutlu L; Wetter A; Theegarten D; Aigner C; Eberhardt WEE; Schuler M; Karpf-Wissel R; Stuschke M
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2894-2903. PubMed ID: 33547554
[TBL] [Abstract][Full Text] [Related]
16. Regional Lymph Node Metastasis Distribution in Resectable Middle-Third Gastric Cancer: A Cross-Sectional Study.
Vu Tuan Anh N; Dang QT; Lam Vuong N; Nguyen VH; Ho LMQ; Tran QD; Dang TT; Tran AM; Doan TN; Nguyen HB; Nguyen TT; Duy Vo L
Cureus; 2023 Jun; 15(6):e41236. PubMed ID: 37397656
[TBL] [Abstract][Full Text] [Related]
17. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
18. Is Lymph Node Size a Reliable Factor for Estimating Lymph Node Metastasis in Early Gastric Cancer?
Kim DJ; Kim W
J Gastric Cancer; 2018 Mar; 18(1):20-29. PubMed ID: 29629217
[TBL] [Abstract][Full Text] [Related]
19. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
20. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
